• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BARD ACCESS SYSTEMS BROVIAC 4.2 FR CATHETER PEEL-APART INTRODUCER KIT WITH SURECUFF TISSUE INGROWTH; PERCUTANEOUS, IMPLANTED, LONG TERM INTRAVASCULAR CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BARD ACCESS SYSTEMS BROVIAC 4.2 FR CATHETER PEEL-APART INTRODUCER KIT WITH SURECUFF TISSUE INGROWTH; PERCUTANEOUS, IMPLANTED, LONG TERM INTRAVASCULAR CATHETER Back to Search Results
Model Number N/A
Device Problem Torn Material (3024)
Patient Problems Complaint, Ill-Defined (2331); Blood Loss (2597)
Event Date 03/31/2017
Event Type  malfunction  
Manufacturer Narrative
The information provided by bard represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bard.The manufacturer has received the sample and will evaluate.Results are expected soon.A lot history review (lhr) review is not possible; the manufacturing lot number that was provided is incorrect.
 
Event Description
It was reported by the facility that the patient was brought to the emergency department with a complete tear on the thin part of the distal extension on the broviac.The patient's mom heard him crying at 3:00 am and when she checked on him the sheet was wet with blood.The patient's mom clamped the line and brought him to the emergency department for repair.The line was repaired.
 
Manufacturer Narrative
The information provided by bard represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bard.The following were reviewed as part of this investigation: patient severity, frequency analysis, applicable previous investigation(s), sample (if available), applicable fmea documents, labeling, and applicable manufacture records.Based on a review of this information, the following was concluded: the complaint of a leak was confirmed, and the cause appears to be use related.The external segment of one 4.2 fr s/l broviac catheter was returned for investigation.The catheter extended 1.9 cm from the distal end of the clamping oversleeve.The cross section at the distal end of the catheter exhibited a glossy and striated surface, which is indicative of sharp instrument cut and is believed to be the location where the catheter was trimmed to make a repair.The printing on the clamping oversleeve was worn near the crimp collar.A longitudinal split was observed in the intermediate tubing just distal to the clamping oversleeve.The ends of the longitudinal split curved, giving the split a c-shape appearance.Under microscopic magnification, the split surfaces of the catheter were smooth and granular.The inner layer of 4.2fr catheter exhibited a c-shaped break in the tubing.The characteristics of the splits are consistent with a rupture due to over-pressurization.Functional testing revealed that the lumen was patent to infusion, but a leak was observed where the catheter was split.The section of tubing distal top the burst site was not returned for investigation.To help maintain catheter patency, flushing frequencies from once daily to once weekly have been found to be effective when the catheter is not in use.Flush with heparin after iv administration of total parenteral nutrition, iv fluids, or after medications.For frequently accessed catheters (accessed at least every 8 hours), flushing with 10 ml of sterile saline without heparin between infusions has been found to be effective.Caution: do not use a syringe smaller than 10 ml to flush or confirm patency.Small syringes can generate very high internal pressures with very little force.The back pressure from an occlusion may not be felt when using a small syringe until damage to the catheter has occurred.A thrombolytic solution may be used to declot the catheter if the lumen is occluded.A lot history review (lhr) review is not possible; the manufacturing lot number that was provided is incorrect.
 
Event Description
It was reported by the facility that the patient was brought to the emergency department with a complete tear on the thin part of the distal extension on the broviac.The patient's mom heard him crying at 3:00 am and when she checked on him the sheet was wet with blood.The patient's mom clamped the line and brought him to the emergency department for repair.The line was repaired.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BROVIAC 4.2 FR CATHETER PEEL-APART INTRODUCER KIT WITH SURECUFF TISSUE INGROWTH
Type of Device
PERCUTANEOUS, IMPLANTED, LONG TERM INTRAVASCULAR CATHETER
Manufacturer (Section D)
BARD ACCESS SYSTEMS
605 n. 5600 w.
salt lake city UT 84116
Manufacturer (Section G)
BARD SHANNON LIMITED -3005636544
san geronimo industrial park
lot #1, road #3, km 79.7
humacao PR 00791
Manufacturer Contact
kelsey erickson
605 n. 5600 w.
salt lake city, UT 84116
8015225937
MDR Report Key6560728
MDR Text Key75157904
Report Number3006260740-2017-00596
Device Sequence Number1
Product Code LJS
UDI-Device Identifier00801741051807
UDI-Public(01)00801741051807
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K830256
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Health Professional
Type of Report Initial,Followup
Report Date 05/24/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/11/2017
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberN/A
Device Catalogue Number0600520
Device Lot NumberHUAV_0291 (INCORRECT)
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer04/25/2017
Is the Reporter a Health Professional? Yes
Event Location Hospital
Date Manufacturer Received05/11/2017
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age11 MO
-
-